National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Uterine Sarcoma Treatment (PDQ®)
Patient Version   Health Professional Version   En español   Last Modified: 05/22/2008



Purpose of This PDQ Summary






General Information About Uterine Sarcoma






Cellular Classification of Uterine Sarcoma






Stage Information for Uterine Sarcoma






Treatment Option Overview






Stage I Uterine Sarcoma






Stage II Uterine Sarcoma






Stage III Uterine Sarcoma






Stage IV Uterine Sarcoma






Recurrent Uterine Sarcoma






Get More Information From NCI






Changes to This Summary (05/22/2008)






More Information



Page Options
Print This Page
Print Entire Document
View Entire Document
E-Mail This Document
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
Quit Smoking Today
NCI Highlights
Report to Nation Finds Declines in Cancer Incidence, Death Rates

High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

The Nation's Investment in Cancer Research FY 2009

Past Highlights
Stage Information for Uterine Sarcoma

The FIGO staging for carcinoma of the corpus uteri has been applied to uterine sarcoma.[1]

Stage I

Stage I sarcoma is confined to the corpus uteri. This stage accounts for 50% of all presentations.

  • Stage IA: tumor limited to endometrium.
  • Stage IB: invasion to less than 50% of the myometrium.
  • Stage IC: invasion to more than 50% of the myometrium.

Stage II

Stage II uterine sarcoma means the cancer has involved the corpus and the cervix but has not extended outside the uterus.

  • Stage IIA: endocervical glandular involvement only.
  • Stage IIB: cervical stromal invasion.

Stage III

Stage III uterine sarcoma means extension outside of the uterus but confined to the true pelvis.

  • Stage IIIA: tumor invades serosa and/or adnexae and/or positive peritoneal cytology.
  • Stage IIIB: metastases to pelvic and/or para-aortic lymph nodes.

Stage IV

Stage IV uterine sarcoma means involvement of the bladder or bowel mucosa or metastasis to distant sites.

  • Stage IVA: tumor invasion of bladder and/or bowel mucosa.
  • Stage IVB: distant metastases, including intra-abdominal and/or inguinal lymph nodes.

References

  1. Shepherd JH: Revised FIGO staging for gynaecological cancer. Br J Obstet Gynaecol 96 (8): 889-92, 1989.  [PUBMED Abstract]

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov